Fluorodeoxyglucose-PET in the management of breast cancer
- 30 November 2004
- journal article
- review article
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 42 (6) , 1113-1122
- https://doi.org/10.1016/j.rcl.2004.08.005
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Magnetic resonance imaging in the preoperative evaluation of breast cancer: primum non nocereJournal of the American College of Surgeons, 2004
- Long-term trends in cancer mortality in the United States, 1930-1998Cancer, 2003
- Evaluation of Fluorodeoxyglucose Positron Emission Tomography in the Detection of Axillary Lymph Node Metastases in Patients With Early-Stage Breast CancerAnnals of Surgical Oncology, 2003
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Lymphatic mapping and sentinel node biopsy in the patient with breast cancerPublished by American Medical Association (AMA) ,1996
- Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistryEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Positron emission tomography: 2-deoxy-2-Z18F]-fluoro-d-glucose uptake in locally advanced breast cancersEuropean Journal of Surgical Oncology, 1995
- Positive predictive value of screening mammography by age and family history of breast cancerPublished by American Medical Association (AMA) ,1993
- Cancer Detection with Whole-Body PET Using 2-[18F]Fluoro-2-Deoxy-D-GlucoseJournal of Computer Assisted Tomography, 1993
- Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancerCancer, 1993